Company: INV
Filing Date: 2025-05-09
Form Type: ARS
Source: 0001628280-25-024065
Chunk: 88

Company: Innventure, Inc.
Filing Date: 2025-05-09
Form: ARS
Chunk 88
---
... — — Common Stock, $0.0001 par value, 250,000,000 shares authorized, and 44,597,154 shares issued and outstanding as of December 31, 2024 ...... 4 — Additional paid-in capital ............................................................................................................................................................................................. 502,865 — Accumulated other comprehensive gain (loss) ............................................................................................................................................................. 909 — Accumulated deficit ...................................................................................................................................................................................................... (78,262) (64,284) Total Innventure, Inc., Stockholders’ Equity/ Innventure LLC Unitholders' Deficit .............................................................................................. 425,516 (20,045) Non-controlling interest ................................................................................................................................................................................................ 340,777 1,559 Total Stockholders' Equity/ Unitholders' Deficit ......................................................................................................................................................... 766,293 (18,486) Total Liabilities, Mezzanine Capital and Equity ......................................................................................................................................................... $ 905,289 $ 21,564 Successor Predecessor December 31, 2024 December 31, 2023 See accompanying notes to consolidated financial statements. Table of Contents Innventure, Inc. and Subsidiaries Consolidated Balance Sheets (in thousands, except share and per share amounts) 61

Successor Predecessor October 2, 2024 through December 31, 2024 January 1, 2024 through October 1, 2024 Year ended December 31, 2023 Revenue $ 456 $ 764 $ 1,117 Operating Expenses Cost of sales ................................................................................................. 3,752 777 — General and administrative .......................................................................... 29,652 26,608 17,589 Sales and marketing ..................................................................................... 2,009 4,178 3,205 Research and development ........................................................................... 5,340 5,978 4,001 Total Operating Expenses ............................................................................... 40,753 37,541 24,795 Loss from Operations ...................................................................................... (40,297) (36,777) (23,678) Non-operating (Expense) and Income Interest expense, net ..................................................................................... (1,132) (1,300) (1,224) Net gain (loss) from investments ................................................................. — 11,547 (6,448) Net (loss) gain on investments - due to related parties ................................ — (468) 232 Change in fair value of financial liabilities .................................................. (20,946) (478) 766 Equity method investment (loss) income ..................................................... (902